Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Citation
Resort to False Fuel Savings
Products
Life, Liberty, And Cell Phones
From the August 2001 Edition of CEI Update A car speeds down a busy highway, zigzagging unpredictably from lane to…
Op-Eds
Plants Are Not Pesticides
Miller Op-Ed in The National Post<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> A New U.S. EPA…
Study
The Leaked Study on CAFE: Why It Doesn’t Justify Higher Fuel Economy Standards
This past Monday, the New York Times carried a front-page story on the National Academy of Sciences’ auto fuel-economy study.[1] The…
Op-Eds
Massachusetts: Go Slow on Disconnecting Drivers
Gattuso and Rupert Op-Ed in The Lowell Sun<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> …
News Release
CEI Criticizes FDA Delay In Approving New Heart Valve
Washington, DC, July 27, 2001—The Food and Drug Administration acted far too slowly in approving the Omnicarbon heart valve, the Competitive Enterprise Institute…